New Treatment for Rheumatoid Arthritis Granted FDA Approval - Pharmacy Times

New Treatment for Rheumatoid Arthritis Granted FDA Approval  Pharmacy Times

Officials with the FDA have approved AbbVie's upadacitinib (Rinvoq) 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment of adults with ...